SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-09-028824
Filing Date
2009-02-13
Accepted
2009-02-13 13:07:47
Documents
1
Group Members
JACOB GOTTLIEB

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 1 dsc13ga.htm SC 13G/A 74659
  Complete submission text file 0001193125-09-028824.txt   76753
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Subject) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-43256 | Film No.: 09600905
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 950 THIRD AVENUE, 29TH FLOOR NEW YORK NY 10022
Business Address 950 THIRD AVENUE, 29TH FLOOR NEW YORK NY 10022 646 840 5847
Visium Asset Management, LP (Filed by) CIK: 0001377452 (see all company filings)

IRS No.: 203313013 | Fiscal Year End: 1231
Type: SC 13G/A